By Use Of Intercalating Agent (e.g., Acridine Orange, Etc.) Patents (Class 435/443)
  • Publication number: 20120244584
    Abstract: The present disclosure provides, inter alia, Thraustochytrium and relevant methods and reagents, including engineered regulatory sequences from and/or operative in Thraustochytrid or Thraustochytrium, selectable markers useful for engineering microorganisms such as Thraustochytrids, means for mutagenizing microorganisms, novel strains produced by mutagenesis, and methods and compositions related to production of particular compounds in microorganisms.
    Type: Application
    Filed: March 7, 2012
    Publication date: September 27, 2012
    Applicant: OCEAN NUTRITION CANADA LIMITED
    Inventors: ShuoCheng Zhang, Roberto Armenta
  • Patent number: 8101386
    Abstract: The present invention relates to the fields of microbiology and microbial genetics. More specifically, the invention relates to novel bacteria strains and processes employing these strains for the fermentative production of amino acids such as threonine.
    Type: Grant
    Filed: June 28, 2010
    Date of Patent: January 24, 2012
    Assignee: Archer Daniels Midland Company
    Inventors: Hungming J. Liaw, Jill S. Bradshaw, Yueqin Yang, Weiying Mao
  • Patent number: 7927606
    Abstract: Free-living microbes are provided in which the nucleic acid has been modified so that the microbe is attenuated for proliferation and/or which comprise genetic mutations that attenuate the ability of the microbe to repair its nucleic acid. Methods of using the modified microbes for the loading, activation, and/or maturation of antigen-presenting cells are also provided. Vaccine compositions comprising the modified microbes and/or the antigen-presenting cells and methods of using the vaccines are also provided. The microbes may be further modified to include heterologous antigens, such as tumor antigens or infectious disease antigens, for use as a vaccine against cancer or infectious diseases.
    Type: Grant
    Filed: August 11, 2006
    Date of Patent: April 19, 2011
    Assignee: Aduro Biotech
    Inventors: Thomas W. Dubensky, Jr., Dirk G. Brockstedt, Keith S. Bahjat, John E. Hearst, David N. Cook, William S. Luckett, Jr.
  • Patent number: 7842289
    Abstract: The present invention provides recombinant nucleic acid molecules, expression cassettes, and vectors useful for expression of polypeptides, including heterologous polypeptides, such as antigens, in bacteria. Some of the recombinant nucleic acid molecules, expression cassettes and vectors comprise codon-optimized sequences encoding the polypeptides and/or signal peptides. Some of the recombinant nucleic acid molecules, expression cassettes, and expression vectors comprise sequences encoding non-Listerial and/or non-secA1 signal peptides for secretion of the polypeptides. The invention also provides bacteria comprising the nucleic acid molecules, expression cassettes, and expression vectors, as well as compositions such as vaccines comprising the bacteria. Methods of making and using the bacteria, recombinant nucleic acid molecules, and expression cassettes are also provided.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: November 30, 2010
    Assignee: Aduro BioTech
    Inventors: Thomas W. Dubensky, Jr., Daniel A. Portnoy, William S. Luckett, Jr., David N. Cook
  • Patent number: 7767431
    Abstract: The present invention relates to the fields of microbiology and microbial genetics. More specifically, the invention relates to novel bacteria strains and processes employing these strains for the fermentative production of amino acids such as threonine.
    Type: Grant
    Filed: April 13, 2007
    Date of Patent: August 3, 2010
    Assignee: Archer-Daniels-Midland Company
    Inventors: Hungming J. Liaw, Jill S. Bradshaw, Yueqin Yang, Weiying Mao
  • Patent number: 7695725
    Abstract: Free-living microbes are provided in which the nucleic acid has been modified so that the microbe is attenuated for proliferation and/or which comprise genetic mutations that attenuate the ability of the microbe to repair its nucleic acid. Methods of using the modified microbes for the loading, activation, and/or maturation of antigen-presenting cells are also provided. Vaccine compositions comprising the modified microbes and/or the antigen-presenting cells and methods of using the vaccines are also provided. The microbes may be further modified to include heterologous antigens, such as tumor antigens or infectious disease antigens, for use as a vaccine against cancer or infectious diseases.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: April 13, 2010
    Assignee: Aduro Biotech
    Inventors: Thomas W. Dubensky, Jr., Dirk G. Brockstedt, John E. Hearst, David N. Cook, William S. Luckett, Jr.
  • Patent number: 7687253
    Abstract: The present invention relates to the fields of microbiology and microbial genetics. More specifically, the invention relates to novel bacteria strains and processes employing these strains for the fermentative production of amino acids such as threonine.
    Type: Grant
    Filed: March 19, 2008
    Date of Patent: March 30, 2010
    Assignee: Archer-Daniels-Midland Company
    Inventors: Hungming J. Liaw, Jill S. Bradshaw, Yueqin Yang, Weiying Mao
  • Publication number: 20090298151
    Abstract: The disclosed invention relates to an isolated hydrogen gas producing microorganism, termed Enterobacter sp. SGT-T4™ and derivatives thereof. Compositions and methods comprising the disclosed microorganisms are also provided.
    Type: Application
    Filed: June 3, 2008
    Publication date: December 3, 2009
    Applicant: Dr. Elmar Schmid and James Gibson
    Inventors: Elmar Schmid, James Gibson
  • Publication number: 20090029433
    Abstract: The disclosed invention relates to an isolated hydrogen gas producing microorganism, termed Enterobacter sp. SGT 06-1™.
    Type: Application
    Filed: July 27, 2007
    Publication date: January 29, 2009
    Applicant: Dr. Elmar Schmid and James Gibson
    Inventors: Elmar Schmid, James Warner Gibson
  • Patent number: 7303897
    Abstract: The invention relates to a fragmentation process that depends on mismatches between two strands of parental polynucleotides. One embodiment, comprises a method for preparing polynucleotide fragments of DNA comprising formation of heteroduplex molecules by hybridizing polynucleotides. The invention also provides a method and process of forming fragments which can be used with any shuffling process or combination of shuffling processes.
    Type: Grant
    Filed: November 17, 2003
    Date of Patent: December 4, 2007
    Assignee: Proteus S.A.
    Inventors: Daniel Dupret, Fabrice Lefevre, Laurent Fourage
  • Patent number: 7220571
    Abstract: The present invention relates to the fields of microbiology and microbial genetics. More specifically, the invention relates to novel bacterial strains and processes employing these strains for the fermentative production of amino acids such as threonine.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: May 22, 2007
    Assignee: Archer-Daniels-Midland Company
    Inventors: Hungming J Liaw, Jill S Bradshaw, Yueqin Yang, Weiying Mao
  • Patent number: 7208317
    Abstract: Cellular libraries useful for in vitro phenotyping and gene mapping. In a representative approach, a method for preparing a homozygous cellular library includes the steps of providing a heterozygous cellular library comprising a plurality of isolated parent cells; inducing site-specific mitotic recombination in the plurality of isolated parent cells; culturing the plurality of isolated parent cells, whereby a population of daughter cells is produced; and selecting daughter cells comprising a homozygous genetic modification, whereby a homozygous cellular library is prepared.
    Type: Grant
    Filed: May 2, 2003
    Date of Patent: April 24, 2007
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: David W. Threadgill, Daekee Lee
  • Patent number: 7078389
    Abstract: A mutagenic, triplex-forming oligonucleotide and methods for use thereof wherein the oligonucleotide is chemically modified to incorporate a mutagen and forms a triple-stranded nucleic acid molecule with a specific DNA segment of a target DNA molecule. Upon formation of the triplex, the mutagen is brought into proximity with the target molecule and causes a mutation at a specific site therein. The mutation activates, inactivates or alters the activity and function of the target molecule.
    Type: Grant
    Filed: February 14, 2001
    Date of Patent: July 18, 2006
    Assignee: Yale University
    Inventors: Peter M. Glazer, Pamela A. Havre
  • Patent number: 6922850
    Abstract: Visor assembly (1, 21) consisting of an inner shield (6, 26) and an outer shield (2, 22). In the use position these shields are some distance apart. With this arrangement the inner shield (6, 26) is located within the peripheral confines of the outer shield (2, 22). The inner shield (6, 26) is provided with an elevation (7, 27) which extends close to the periphery thereof and which acts as a spacer with respect to the outer shield. This elevation (7, 27) is preferably made of silicone material which is snack to the inner shield (6, 26) but is not stuck to the outer shield (2, 22). Fixing to the outer shield (2, 22) takes place by means (10, 12) of mechanical fixing means.
    Type: Grant
    Filed: August 24, 2000
    Date of Patent: August 2, 2005
    Assignee: Derek's Patent B.V.
    Inventor: Derek Leslie Arnold
  • Patent number: 6835867
    Abstract: The present invention relates to methods of producing an allelic series of modifications in genes of interest in a cell. In particular, the invention provides methods for using nucleic acid sequence-modifying agents (e.g., chemicals, electromagnetic radiation, etc.) to introduce modifications in any nucleic acid sequence in the genome of a cell. Also provided are sets of cells which contain at least one modification in any gene of interest. The methods and compositions of the invention are useful in determining the function of the gene of interest.
    Type: Grant
    Filed: June 24, 1998
    Date of Patent: December 28, 2004
    Inventors: Richard P. Woychik, Terry R. Magnuson, Ellis D. Avner, James W. Thomas
  • Patent number: 6696294
    Abstract: The present invention provides methods for generating and identifying mutations in any target gene of a polyploid plant species. In a preferred aspect of the present invention, a plant is constructed and/or selected that has at least one copy of a functional, target gene located exclusively in only one of its homoeologous, or homologous, genomes. Seed derived from the selected plant are then contacted with an effective amount of at least one mutagenic agent, the treated seed are germinated and the seeds or plants derived therefrom, are screened for mutations in the target gene. Thus, the inventive concepts set forth herein can be used to create, select and identify mutations in any target gene of any suitable polyploid plant, thereby providing a source of numerous, readily-identifiable mutations that can, if so desired, be used in crosses to develop unique new crop cultivars.
    Type: Grant
    Filed: December 18, 2000
    Date of Patent: February 24, 2004
    Assignee: Northwest Plant Breeding Co.
    Inventor: Calvin F. Konzak
  • Publication number: 20030113759
    Abstract: Disclosed is a process of performing “sexual” PCR which includes generating random polynucleotides by interrupting or blocking a synthesis or amplification process to show or halt synthesis or amplification of at least one polynucleotide, optionally amplifying the polynucleotides, and reannealing the polynucleotides to produce random mutant polynucleotides. Also provided are vector and expression vehicles including such mutant polynucleotides, polypeptides expressed by the mutant polynucleotides and a method for producing random mutant polypeptides.
    Type: Application
    Filed: August 12, 2002
    Publication date: June 19, 2003
    Inventor: Jay M. Short
  • Publication number: 20030068808
    Abstract: The invention provides methods for generating antibiotic resistant bacteria comprising blocking mismatch repair in a bacterium to make hypermutable bacteria, contacting the bacteria with at least one antibiotic, selecting bacteria that are resistant to the antibiotic, and culturing the antibiotic resistant bacteria. The invention also provides methods of determining the genes responsible for antibiotic resistance.
    Type: Application
    Filed: July 25, 2001
    Publication date: April 10, 2003
    Inventors: Nicholas C. Nicolaides, Philip M. Sass, Luigi Grasso, J. Bradford Kline
  • Publication number: 20020106800
    Abstract: The present invention relates to the fields of microbiology and microbial genetics. More specifically, the invention relates to novel bacterial strains and processes employing these strains for the fermentative production of amino acids such as threonine.
    Type: Application
    Filed: September 26, 2001
    Publication date: August 8, 2002
    Inventors: Hungming J. Liaw, Jill S. Bradshaw, Yueqin Yang, Weiying Mao
  • Publication number: 20020068053
    Abstract: The invention relates to a pharmaceutical preparation comprising tumor-reactive cells similar to Th1 which produce large quantities of interferon &ggr; and produce little or no interleukin 4; together with pharmaceutically compatible excipients and auxiliary agents. The invention also relates to a method for producing tumor-reactive cells similar to Th1 which produce large quantities of interferon &ggr; and produce little or no interleukin 4.
    Type: Application
    Filed: August 16, 2001
    Publication date: June 6, 2002
    Inventors: Martin Rocken, Oliver Egeter, Ralph Mocikat
  • Publication number: 20020028922
    Abstract: A mutagenic, triplex-forming oligonucleotide and methods for use thereof wherein the oligonucleotide is chemically modified to incorporate a mutagen and forms a triple-stranded nucleic acid molecule with a specific DNA segment of a target DNA molecule. Upon formation of the triplex, the mutagen is brought into proximity with the target molecule and causes a mutation at a specific site therein. The mutation activates, inactivates or alters the activity and function of the target molecule.
    Type: Application
    Filed: February 14, 2001
    Publication date: March 7, 2002
    Inventors: Peter M. Glazer, Pamela A. Havre
  • Patent number: 6303376
    Abstract: A high affinity, triplex-forming oligonucleotide and methods for use thereof wherein an oligonucleotide is used to form a triple-stranded nucleic acid molecule with a specific DNA segment of a target DNA molecule. Upon formation of the triplex, the binding of the oligonucleotide stimulates mutagenesis within or adjacent to the target sequence using cellular DNA synthesis or repair mechanisms. The mutation activates, inactivates or alters the activity and function of the target molecule.
    Type: Grant
    Filed: October 4, 1999
    Date of Patent: October 16, 2001
    Assignee: Yale University
    Inventor: Peter M. Glazer
  • Patent number: 6300317
    Abstract: This invention provides a self-assembling polynucleotide delivery system comprising components aiding in the delivery of the polynucleotide to the desired address which are associated via noncovalent interactions with the polynucleotide. The components of this system include DNA-masking components, cell recognition components, charge-neutralization and membrane-permeabilization components, and subcellular localization components. Specific compounds useful in this system are also provided.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: October 9, 2001
    Assignee: The Regents of the University of California
    Inventors: Francis C. Szoka, Jr., Jean Haensler
  • Patent number: 6271007
    Abstract: The invention relates to novel yeast strains having a reduced ability to metabolize xylitol. The invention further relates to the use of said strains for the production of xylitol.
    Type: Grant
    Filed: February 7, 1994
    Date of Patent: August 7, 2001
    Assignee: Xyrofin Oy
    Inventors: Juha Apajalahti, Matti Leisola
  • Patent number: 5955365
    Abstract: This invention provides a self-assembling polynucleotide delivery system comprising components aiding in the delivery of the polynucleotide to the desired address which are associated via noncovalent interactions with the polynucleotide. The components of this system include DNA-masking components, cell recognition components, charge-neutralization and membrane-permeabilization components, and subcellular localization components. Specific compounds useful in this system are also provided.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 21, 1999
    Assignee: Regents of the University of California
    Inventors: Francis C. Szoka, Jr., Jean Haensler
  • Patent number: 5795802
    Abstract: A method for manufacturing a semiconductor device, the method includes the steps of forming an n-type well and a p-type well under a surface of a semiconductor substrate, forming a pad oxide layer having a first thickness on the p-type well and a second thickness on the n-type well, the first thickness being greater than the second thickness, and forming a field oxide layer between the n-type well and the p-type well, the field oxide layer having less bird's beak on the n-type well than on the p-type well.
    Type: Grant
    Filed: September 3, 1997
    Date of Patent: August 18, 1998
    Assignee: LG Semicon Co., Ltd.
    Inventors: Sang-Gi Ko, Mun-Mo Jeong
  • Patent number: RE44250
    Abstract: Visor assembly (1, 21) consisting of an inner shield (6, 26) and an outer shield (2, 22). In the use position these shields are some distance apart. With this arrangement the inner shield (6, 26) is located within the peripheral confines of the outer shield (2, 22). The inner shield (6, 26) is provided with an elevation (7, 27) which extends close to the periphery thereof and which acts as a spacer with respect to the outer shield. This elevation (7, 27) is preferably made of silicone material which is snack to the inner shield (6, 26) but is not stuck to the outer shield (2, 22). Fixing to the outer shield (2, 22) takes place by means (10, 12) of mechanical fixing means.
    Type: Grant
    Filed: August 24, 2000
    Date of Patent: June 4, 2013
    Assignee: Derek's Patent B.V.
    Inventor: Derek Leslie Arnold